美国 · SEC FORM 4
Absci Corp
ABSI · Nasdaq · CIK 0001672688 · Healthcare · Biotechnology
内部人信号
2 位买方 · 2 条买入交易行 · $349.6K 买入总额
为什么有这个信号？
评分构成
每条进度条表示其对当前分数的贡献；权重和公式保持不变。
哪些因素限制了当前分数？
- ⚠ Cluster breadth is moderate · 2 insider(s), not 4+
- ⚠ Purchase activity is becoming less recent
- ✓ 角色得分高 · 买入者中职位最高的是：Director
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 3 additional owner(s) remain in Form 4 申报证据.
买方广度与集中度
Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
最新留档分数
- 58.9
- 58.9
- 58.8
- 58.7
- 58.6
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- +23.3%
- 3M
- -0.5%
- 6M
- +240.9%
- 12M
- +143.1%
波动率与流动性
- 波动率
- 101.6%
- Beta
- 2.44
- 平均每日成交额
- USD 35.1M
估值
- 市值
- USD 1.7B
- P/E
- —
基本面
- 利润率
- 0.0%
- ROE
- -60.8%
- 细分行业
- Biotechnology
市场数据
价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance · 来自 SEC 申报文件：市值, ROE · 财年截止日：2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-07-31 · 来自 Yahoo Finance：利润率 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 37,442,385
- 上期报告
- 37,255,325
- 日均成交量
- 4,977,529
- 回补天数
- 7.5
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Szela Mary T | 买入 (P) | Common Stock | 12,900 | USD 11.54 | USD 148,866 | SEC 申报 ↗ |
| 2026-05-13 | Pangalos Menelas N | 买入 (P) | Common Stock | 37,453 | USD 5.36 | USD 200,748 | SEC 申报 ↗ |
| 2026-03-12 | Busch Andreas | 买入 (P) | Common Stock | 100,000 | USD 2.29 | USD 229,000 | SEC 申报 ↗ |
| 2026-02-27 | Pangalos Menelas N | 买入 (P) | Common Stock | 75,095 | USD 2.74 | USD 205,760 | SEC 申报 ↗ |
| 2025-12-05 | VAN HOUTEN FRANS | 买入 (P) | Common Stock | 40,000 | USD 3.72 | USD 148,800 | SEC 申报 ↗ |
| 2025-09-22 | Pangalos Menelas N | 买入 (P) | Common Stock | 95,785 | USD 2.66 | USD 254,788 | SEC 申报 ↗ |
| 2025-09-22 | Bedrick Todd | 买入 (P) | Common Stock | 10,000 | USD 2.70 | USD 27,000 | SEC 申报 ↗ |
| 2025-07-28 | Busch Andreas | 买入 (P) | Common Stock | 50,000 | USD 3.04 | USD 152,000 | SEC 申报 ↗ |
| 2024-03-01 | Green Jeremy; Redmile Group, LLC | 买入 (P) | Common Stock | 222,222 | USD 4.50 | USD 999,999 | SEC 申报 ↗ |
| 2022-02-09 | Korman Sarah | 买入 (P) | Common Stock | 4,250 | USD 7.96 | USD 33,830 | SEC 申报 ↗ |
| 2022-01-20 | Bedrick Todd | 买入 (P) | Common Stock | 2,000 | USD 7.50 | USD 15,000 | SEC 申报 ↗ |
| 2022-01-19 | McClain Sean | 买入 (P) | Common Stock | 7,155 | USD 6.92 | USD 49,513 | SEC 申报 ↗ |
| 2021-07-26 | McClain Sean | 买入 (P) | Common Stock | 600 | USD 16.00 | USD 9,600 | SEC 申报 ↗ |
| 2021-07-26 | MCGINNIS KAREN K | 买入 (P) | Common Stock | 15,000 | USD 16.00 | USD 240,000 | SEC 申报 ↗ |
| 2021-07-26 | Korman Sarah | 买入 (P) | Common Stock | 10,000 | USD 16.00 | USD 160,000 | SEC 申报 ↗ |
Form 4 申报证据
47 transaction lines in the latest 365-day window; 133 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-12 | McClain Sean | 代扣税 (F) | Common Stock | 23,293 | USD 10.16 | USD 236,657 | SEC 申报 ↗ |
| 2026-10-12 | Jonasson Zachariah | 代扣税 (F) | Common Stock | 387 | USD 10.16 | USD 3,932 | SEC 申报 ↗ |
| 2026-10-12 | Bedrick Todd | 代扣税 (F) | Common Stock | 22,325 | USD 10.16 | USD 226,822 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-12 | McClain Sean | 代扣税 (F) | Common Stock | 23,293 | USD 10.16 | USD 236,657 | SEC 申报 ↗ |
| 2026-10-12 | Jonasson Zachariah | 代扣税 (F) | Common Stock | 387 | USD 10.16 | USD 3,932 | SEC 申报 ↗ |
| 2026-10-12 | Bedrick Todd | 代扣税 (F) | Common Stock | 22,325 | USD 10.16 | USD 226,822 | SEC 申报 ↗ |
| 2026-08-31 | Jonasson Zachariah | 代扣税 (F) | Common Stock | 8,320 | USD 8.71 | USD 72,467 | SEC 申报 ↗ |
| 2026-06-30 | Szela Mary T | 买入 (P) | Common Stock | 12,900 | USD 11.54 | USD 148,866 | SEC 申报 ↗ |
| 2026-06-24 | McClain Sean | 代扣税 (F) | Common Stock | 59,896 | USD 10.08 | USD 603,752 | SEC 申报 ↗ |
| 2026-06-04 | Szela Mary T | 奖励／授予 (A) | Common Stock | 8,400 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | MCGINNIS KAREN K | 奖励／授予 (A) | Common Stock | 10,100 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | VAN HOUTEN FRANS | 奖励／授予 (A) | Common Stock | 10,100 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | Szela Mary T | 奖励／授予 (A) | Common Stock | 10,100 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | Sirosh Joseph | 奖励／授予 (A) | Common Stock | 10,100 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | Rabinovitsj Daniel A | 奖励／授予 (A) | Common Stock | 10,100 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | Pangalos Menelas N | 奖励／授予 (A) | Common Stock | 10,100 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-31 | Jonasson Zachariah | 代扣税 (F) | Common Stock | 8,319 | USD 6.75 | USD 56,153 | SEC 申报 ↗ |
| 2026-05-13 | Pangalos Menelas N | 买入 (P) | Common Stock | 37,453 | USD 5.36 | USD 200,748 | SEC 申报 ↗ |
| 2026-03-12 | Busch Andreas | 买入 (P) | Common Stock | 100,000 | USD 2.29 | USD 229,000 | SEC 申报 ↗ |
| 2026-03-03 | Walker Shelby J. | 代扣税 (F) | Common Stock | 9,825 | USD 2.80 | USD 27,510 | SEC 申报 ↗ |
| 2026-03-03 | McClain Sean | 代扣税 (F) | Common Stock | 25,316 | USD 2.80 | USD 70,885 | SEC 申报 ↗ |
| 2026-03-03 | Jonasson Zachariah | 代扣税 (F) | Common Stock | 10,848 | USD 2.80 | USD 30,374 | SEC 申报 ↗ |
| 2026-03-03 | Bedrick Todd | 代扣税 (F) | Common Stock | 5,282 | USD 2.80 | USD 14,790 | SEC 申报 ↗ |
| 2026-03-03 | Walker Shelby J. | 代扣税 (F) | Common Stock | 9,825 | USD 2.80 | USD 27,510 | SEC 申报 ↗ |
| 2026-03-03 | McClain Sean | 代扣税 (F) | Common Stock | 25,316 | USD 2.80 | USD 70,885 | SEC 申报 ↗ |
| 2026-03-03 | Jonasson Zachariah | 代扣税 (F) | Common Stock | 10,848 | USD 2.80 | USD 30,374 | SEC 申报 ↗ |
| 2026-03-03 | Busch Andreas | 代扣税 (F) | Common Stock | 1,257 | USD 2.80 | USD 3,520 | SEC 申报 ↗ |
| 2026-03-03 | Bedrick Todd | 代扣税 (F) | Common Stock | 5,282 | USD 2.80 | USD 14,790 | SEC 申报 ↗ |
| 2026-03-02 | Walker Shelby J. | 奖励／授予 (A) | Common Stock | 90,300 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-02 | McClain Sean | 奖励／授予 (A) | Common Stock | 406,200 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-02 | Jonasson Zachariah | 奖励／授予 (A) | Common Stock | 135,400 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-02 | Bedrick Todd | 奖励／授予 (A) | Common Stock | 49,600 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-02 | Pangalos Menelas N | 奖励／授予 (A) | Common Stock | 5,800 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | ABSI |
| CIK | 0001672688 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 8731 Services-Commercial Physical & Biological Research |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 133 transaction lines from 2021-07-26 to 2026-10-12 20 P purchase lines · 11 S sale lines · 102 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.